BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13872624)

  • 1. [The enzymogram in chronic hepatitis and hepatic cirrhosis].
    BRAUNER R; SORU E; IULIAN M; NEGOESCU V; HOANCA O
    Rev Int Hepatol; 1961; 11():509-28. PubMed ID: 13872624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on hepatic gluconeogenesis in chronic liver diseases; with special references to the effects of L-alanine administration].
    Nishimura A
    Nihon Shokakibyo Gakkai Zasshi; 1984 Nov; 81(11):2754-66. PubMed ID: 6097722
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of zinc content in blood, liver tissue, urine and hair of patients with chronic liver diseases and its clinical significance].
    Dang ZD
    Zhonghua Nei Ke Za Zhi; 1983 Dec; 22(12):758-60. PubMed ID: 6675940
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolic changes produced by surgical stress and postoperative liver failure in liver disease patients].
    Fluture V; Onisei O; Lupşa I; Nistor C; Bilegan C; Roştaru M; Mihalaş G
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1986; 35(3):221-32. PubMed ID: 2944175
    [No Abstract]   [Full Text] [Related]  

  • 5. [Xylitol metabolism in hepatic diseases].
    Kato K
    Nihon Shokakibyo Gakkai Zasshi; 1972 Nov; 69(11):1137-50. PubMed ID: 4675354
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clevage of exogenous lipids in patients with chronic hepatic disease].
    Shaternikov VA; Loranskaia TI; Beiul EA; Savchuk LA
    Vopr Pitan; 1969; 28(2):11-6. PubMed ID: 5367242
    [No Abstract]   [Full Text] [Related]  

  • 7. The hepatic glutathione content in liver diseases.
    Poulsen HE; Ranek L; Andreasen PB
    Scand J Clin Lab Invest; 1981 Oct; 41(6):573-6. PubMed ID: 7336124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein Expression in Dogs With Chronic Hepatitis and Its Correlation With Hepatic Fibrosis, Inflammation, and Ki-67 Expression.
    Sridharan S; Allen AL; Kidney B; Al-Dissi AN
    Vet Pathol; 2015 Nov; 52(6):1127-33. PubMed ID: 26077783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens: support for the intact-hepatocyte theory.
    Meyer B; Luo HS; Bargetzi M; Renner EL; Stalder GA
    Hepatology; 1991 Mar; 13(3):475-81. PubMed ID: 1671846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatic and renal elimation of bromsulphalein in chronic hepatitis, post-inflammatory cirrhosis and obstructive jaundice].
    Babiuch L
    Przegl Epidemiol; 1975; 29(2):159-67. PubMed ID: 1144806
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the histopathology of liver injury, especially of cirrhosis in connection with the liver content of copper and iron. Differentiation by histochemical and quantitative chemical assay].
    NISHIMURA H
    Acta Pathol Jpn; 1962 Jan; 12():59-89. PubMed ID: 14479972
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism.
    Farrell GC; Cooksley WG; Hart P; Powell LW
    Gastroenterology; 1978 Oct; 75(4):580-8. PubMed ID: 710827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide dismutase and glutathione in the gastric mucosa of patients with chronic liver disease.
    Kikkawa S; Kadohara M; Kawasaki H
    Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):289-309. PubMed ID: 1335597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deranged metabolism of cyclic nucleotides in liver diseases.
    Matsushima T; Maekubo H; Yoshida T; Taneda H; Yoshida J; Miyazaki T; Okada F
    Horm Metab Res; 1985 Jun; 17(6):306-7. PubMed ID: 2991101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of (131-I)gamma globulins in patients with chronic liver disease.
    Hirayama C; Fukuda T; Toda T
    Clin Chim Acta; 1970 Mar; 27(3):409-13. PubMed ID: 4190908
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of polyunsaturated phosphatidylcholine and vitamin B complex on the metabolism of selenium homotaurocholic acid in patients with chronic liver disease].
    Indovina I; Scaffidi A; Costa R
    Minerva Med; 1987 Mar; 78(6):369-72. PubMed ID: 3561846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of the isotope method for studying albumin metabolism in patients with chronic liver diseases].
    Vinogradov VA; Baranenkov AI
    Ter Arkh; 1974; 46(3):118-23. PubMed ID: 4828489
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium metabolism in chronic liver disease.
    Gossman H; Bode G; Baltzer G; Dombrowski H; Martini GA
    Calcif Tissue Res; 1968; ():Suppl:64-64a. PubMed ID: 5721085
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased S100B expression in chronic liver diseases.
    Baik SJ; Kim TH; Yoo K; Moon IH; Choi JY; Chung KW; Song DE
    Korean J Intern Med; 2017 Mar; 32(2):269-276. PubMed ID: 27255110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iron metabolism and enteral iron absorption in liver diseases].
    Rommel K; Gladtke E; Mähr G; Grimmel K; Burkhardt H
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1854-9. PubMed ID: 5704710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.